We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA tells patients and healthcare professionals to stop using affected gels and retailers told to withdraw affected products.
Patients, or carers of patients, who carry Emerade 300 or 500 microgram adrenaline auto-injector pens should contact their GP and obtain a prescription for, and be supplied with an alternative brand. They should then return …
Patients, carers and healthcare professionals with kits of the opioid overdose medicine Prenoxad Injection must visually check for the presence of two needles inside their kit. Any kits that do not have two needles should be…
Patients using antibiotic Targocid 200mg powder at home must check if the batch number of their medicine is 0J25D1 or 0J25D2. Anyone who has one of these two batches should stop their treatment and seek immediate medical adv…
The safety of the medicines you and your children take is our highest priority
The UK regulator has taken safety action to reduce risks associated with Roche Accu-Chek Insight Insulin Pumps by issuing a national safety alert and outlining recommendations for patients.
This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
The labelling states an incorrect maximum daily dose for 12-15-year olds. The MHRA, who issued the recall, says that that the risk to patients is very low.
Patients should not stop any treatments without consulting their doctor or pharmacist.
Patients should not stop any treatments without consulting their doctor or pharmacist
Batch Number 1K10121 has been found to potentially have the wrong amount of active ingredients
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
Patients are urged to stop taking 5mg ulipristal acetate as soon as possible and contact a healthcare professional for advice on alternative treatments.
A drug alert has been issued to retailers and healthcare professionals as 4 companies are recalling batches of certain over-the-counter Ranitidine medicines used to treat conditions such as stomach ulcers and heartburn.
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
The MHRA has issued alerts to healthcare professionals and retailers, as Perrigo Company plc is recalling all unexpired stock of certain batches of Ranitidine medicines used to treat conditions such as heartburn and stomach …
As a precautionary measure, patients taking certain types of prescription-only medicines for Parkinson’s (Neupro) and epilepsy (Vimpat) are asked to check to see if they have products from batches of medicines which are bein…
MHRA has recalled 3 batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).